✦ LIBER ✦

Long-term outcome of postoperative interferon-α adjuvant therapy for non-metastatic renal cell carcinoma

✍ Scribed by AKINOBU GOTOH; TOSHIRO SHIRAKAWA; NOBUYUKI HINATA; YOSHITAKA WADA; ISAO HARA; MASATO FUJISAWA; GAKU KAWABATA; HIROSHI OKADA; SOICHI ARAKAWA; SADAO KAMIDONO

Book ID: 108976507
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 226 KB
Volume: 11
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2004.00798.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dendritic cell therapy in combination wi

Dendritic cell therapy in combination with interferon-α for the treatment of metastatic renal cell carcinoma

✍ Katsunori Tatsugami; Masatoshi Eto; Masahiko Harano; Masumitsu Hamaguchi; Toshih 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Thirteen-year, long-term efficacy of int

Thirteen-year, long-term efficacy of interferon 2α and interleukin 2-based home therapy in patients with advanced renal cell carcinoma

✍ Jens Atzpodien; Reinhard Hoffmann; Marcus Franzke; Christian Stief; Thomas Wande 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Background: The goal of the current report was to demonstrate the long-term efficacy of outpatient subcutaneous (sc) interferon alpha (ifn-alpha) and sc interleukin 2 (il-2)-based combination regimens in patients with metastatic renal cell carcinoma. ## Methods: In three consecutive clinical t

Clinical outcome of combined immunothera

Clinical outcome of combined immunotherapy with low-dose interleukin-2 and interferon-α for Japanese patients with metastatic renal cell carcinoma who had undergone radical nephrectomy: a preliminary report

✍ Hideaki Miyake; Isao Hara; Iori Sakai; Ken-ichi Harada; Taka-aki Inoue; Hiroshi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 244 KB